Champignon Brands Inc.

CNSX: SHRM


Canadian symbol: SHRM.CN
US symbol: SHRMF


mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
SHRM.CN
Champignon Brands
1 week ago
SHRM.CN
Champignon Brands
4 months ago
SHRM.CN
Champignon Brands
10 months ago
SHRM.CN
Champignon Brands
10 months ago
SHRM.CN
Champignon Brands
10 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
11 months ago
SHRM.CN
Champignon Brands
12 months ago
SHRM.CN
Champignon Brands
12 months ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago
SHRM.CN
Champignon Brands
1 year ago



Insiders transactions are updated every hour.
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Champignon Brands Inc.


Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities

TORONTO, May 3, 2021 - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), is pleased to announce that it has changed its name from "Champignon Brands Inc." to "Braxia Scientific Corp." and its ticker symbol will change from "SHRM" to "BRAX" on the Canadian Securities Exchange (the "CSE").  The name change refle... Read More...

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, BC, March 4, 2021 - AZN Capital Corp. (the "Company" or "AZN") (TSXV: AZN) (OTC: AZNVF) is pleased to announce that it has received in excess of $900,000 from the exercise of warrants, options and brokers warrants since early February 2021.As previously announced, substantially all of the assets of the Company and its U.S. subs... Read More...

AZN Capital Provides Corporate Update

VANCOUVER, BC, March 4, 2021 - AZN Capital Corp. (the "Company" or "AZN") (TSXV: AZN) (OTC: AZNVF) is pleased to announce that it has received in excess of $900,000 from the exercise of warrants, options and brokers warrants since early February 2021.As previously announced, substantially all of the assets of the Company and its U.S. subs... Read More...

Golden Star Resources Reports Results for the Three and Twelve Months Ended December 31, 2020 Delivering on Increased 2020 Production Guidance at Wassa

- A $72M investmentLAVAL, QC, Nov. 12, 2020 /CNW Telbec/ - Urbania Development Corporation Inc., in partnership with the Fonds immobilier de solidarité FTQ, announces "Urbania haus": a unique residential complex situated in a strategic area of Laval, a stone's throw from the Montmorency metro station, Place Bell, university campuses, Coll... Read More...

Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Third CRTCE Clinic effectively addresses the unmet need of depression and suicide VANCOUVER, BC, Jan. 25, 2021 - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the opening of a new Canadian Rapid Treatment Center of Excellence (CRTCE) clinic in Ottawa, Ontario... Read More...

Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life

VANCOUVER, BC, Jan. 8, 2021 - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announces the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc. The article – Bipolar Disorders – is published in one of the world's best-known and most reputable scientific journals in medicine - T... Read More...

Champignon Provides Update on Disclosure Review

VANCOUVER, British Columbia, Sept. 15, 2020 -- Champignon Brands Inc. (CSE: SHRM) (the “Company”) continues to work with the British Columbia Securities Commission (the “Commission”) to address an ongoing continuous disclosure review. Since the review was commenced, the Company has arranged for:Filing of business acquisition reports (coll... Read More...

Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

VANCOUVER, British Columbia, Aug. 27, 2020 -- Champignon Brands Inc. (CSE: SHRM) (the “Company” or “Champignon”) is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic starting in September 2020. Ketamine was declare... Read More...

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

VANCOUVER, British Columbia, July 24, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) is pleased to announce it has filed business acquisition reports in connection with its previous acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp. Copies of t... Read More...

Champignon Announces Regulatory Review

VANCOUVER, British Columbia, June 22, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF) announces that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”).  The review relates to the Company’s disclosure obligations since it became ... Read More...

Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals

VANCOUVER, British Columbia, June 19, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (MDD) ... Read More...

Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

VANCOUVER, British Columbia, June 12, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, since commencing trading on March 2, 2020 has expanded its initiatives and rapidly executed on such initiat... Read More...

Champignon Announces Closing of $15 Million Bought Deal Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 11, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is please... Read More...

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

VANCOUVER, British Columbia, June 08, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to announce it has selected Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemi... Read More...

Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services

VANCOUVER, British Columbia, May 29, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announces that certain shareholders have agreed to a voluntary resale restriction period covering 17,8... Read More...

Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors

VANCOUVER, British Columbia, May 25, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to augment its board of directors through the appointment of accomplished business executives and ... Read More...

Champignon Sponsors Non-profit Coalition, TheraPsil – Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals

VANCOUVER, British Columbia, May 18, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, is pleased to sponsor TheraPsil, a BC-based non-profit coalition of healthcare professionals, policy-makers ... Read More...

Champignon Expands to U.S., To Acquire California Based Ketamine Centre – Wellness Clinic of Orange County

VANCOUVER, British Columbia, May 12, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine is pleased to announce that it has executed a term sheet (the “Term Sheet”) with California, U.S. based Welln... Read More...

Le traitement à base de kétamine de Champignon sera distribué par une importante chaîne de pharmacie canadienne et la compagnie annonce la clôture de la transaction d’AltMed

VANCOUVER, Colombie-Britannique, April 30, 2020 -- Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTCQB : SHRMF), une société des sciences de l’optimisation humaine concentrée sur l’application de nouveaux protocoles de traitement naturels mettant l’accent sur la médecine psychédélique afin de traiter ... Read More...

Champignon Ketamine Treatment to be Dispensed by Major Canadian Pharmacy Chain; Closes AltMed

VANCOUVER, British Columbia, April 30, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, contin... Read More...

Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE

VANCOUVER, British Columbia, April 28, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is ple... Read More...

Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol “SHRMF”

VANCOUVER, British Columbia, April 23, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to anno... Read More...

Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

VANCOUVER, British Columbia, April 22, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to advan... Read More...

Champignon Receives DTC Eligibility

VANCOUVER, British Columbia, April 17, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to anno... Read More...

Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

VANCOUVER, British Columbia, April 16, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, has further bolste... Read More...

Champignon to Acquire AltMed Capital Corp.

VANCOUVER, British Columbia, April 09, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accel... Read More...

Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine

NEW YORK, April 01, 2020 -- via NetworkWire — Champignon Brands Inc. (SHRMF) (SHRM.CN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.To view the full publication,... Read More...

Champignon Appoints University Of Toronto Clinical Advisor, Pharmacognosist To Special Advisory Committee

VANCOUVER, British Columbia, March 31, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to augme... Read More...

Champignon Expands Preclinical Pipeline With Measured Psilocybin Dosages Studies At University Of Miami

VANCOUVER, British Columbia, March 27, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, has entered into a definitiv... Read More...

Champignon Brands Appoints Dr. Joseph Gabriele, Ernst & Young 2018 Health Care Entrepreneur Of The Year And Delivra™ Inventor To Special Advisory Committee

VANCOUVER, British Columbia, March 25, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, continues ... Read More...

CEO of Champignon Brands Shares Strategic Goals in Exclusive NetworkNewsWire Broadcast

NEW YORK, March 23, 2020 -- via NetworkNewsAudio – Champignon Brands Inc. (SHRM.CN) today announces the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”).The interview can be heard at: http://nnw.fm/S39TuChampignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith in an... Read More...

Champignon Brands Announces Normal Course Issuer Bid For Common Shares Of The Corporation

VANCOUVER, British Columbia, March 20, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and novel delivery platforms for the pharmaceutical and nutraceutical industries, is pleased to announce it intends... Read More...

Champignon Brands Expands Alternative Medicine Ip Portfolio With Ketamine, Adaptogenic Delivery Systems/formulations

VANCOUVER, British Columbia, March 19, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and mushroom-infused products, today introduces new proprietary intellectual property (“IP”) into its vertically in... Read More...

Champignon Brands Inc. Completes Initial Public Offering

VANCOUVER, British Columbia, Feb. 28, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) is pleased to announce that it successfully completed its initial public offering (the “IPO”) of 18,916,667 common shares (the “Shares”) of Champignon at a price of $0.15 per Share for total gross proceeds of $2,837,500.05 (the “... Read More...
Coming Soon.

Delayed data (1h)


Share this page